Ebit Veränderung Datum
AbbVie USD 6.88B 156M 2026-09
Align Technology USD 193.04M 1.72M 2026-09
Bayer EUR 129M 626M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Charles River Laboratories USD 221.85M 101.96M 2026-09
Coherus Biosciences USD -39.08M 3.65M 2025-12
Dentsply International USD 38M 46M 2026-09
Eli Lilly USD 13.09B 635M 2026-09
Henry Schein USD 205M 5M 2026-09
Idexx Laboratories USD 402.35M 23.22M 2026-09
Illumina USD 305M 45M 2026-09
IQVIA Holdings USD 608M 1.99B 2026-09
J&J USD 6.47B 1B 2026-09
Laboratory Of America USD 418M 38.7M 2026-09
Merck USD 7.33B 6.49B 2026-09
Neogen USD -1.8M 4.9M 2026-06
Pacira USD 2.57B 2.56B 2026-09
Perrigo USD 27.2M 116.6M 2026-09
Pfizer USD 4.85B 5.03B 2026-09
Phibro Animal Health USD 54.99M 2.36M 2025-12
Quest Diagnostics USD 479M 20M 2026-09
Sanofi EUR 4.72B 3.6B 2026-09
Sanofi EUR 1.12B 1.06B 2026-06
Zoetis USD 1.03B 88M 2026-09